There are a number of great companies in the market today, but there are also a number of companies that are vastly overvalued by the market. By using the ModernGraham Valuation Model, I’ve selected the ten most overvalued companies of the S&P 500 recently reviewed by ModernGraham.
Tag: HCP
HCP Inc Valuation – January 2019 $HCP
HCP, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg ratio.
HCP Inc Valuation – March 2018 $HCP
HCP, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg ratio.
HCP Inc Valuation – January 2016 Update $HCP
HCP Inc qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, the insufficient earnings growth over the last ten years, and the high PEmg ratio.
13 Best Stocks For Value Investors This Week – 10/17/15
We evaluated 25 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Out of those 25 companies, only 13 were found to be undervalued or fairly valued and suitable for either Defensive or Enterprising Investors.
HCP Inc. Valuation – October 2015 Update $HCP
HCP Inc. qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years and high PEmg ratio.
18 Companies in the Spotlight This Week – 10/25/14
We evaluated 18 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.
HCP Inc. Annual Stock Valuation – 2014 $HCP
HCP Inc. does not qualify for either the Defensive Investor or the Enterprising Investor at this time. The Defensive Investor has concerns with the current ratio as well as the level of earnings growth over the last ten years.
5 Undervalued Companies to Research With a Low Beta – October 2014
I’ve selected the five undervalued companies reviewed by ModernGraham with the lowest beta. A company’s beta indicates the correlation at which its price moves in relation to the market. A beta less than 1 indicates a company is less volatile than the market. Each company has been determined to be suitable for either the Defensive Investor or the Enterprising Investor according to the ModernGraham approach. Here’s a summary of each company’s valuation.
5 Highest Dividend Yields Among Undervalued Companies for the Defensive Investor – September 2014
I’ve selected the five highest dividend yields among the undervalued companies reviewed by ModernGraham. Each company has been determined to be suitable for Defensive Investor according to the ModernGraham approach. Here’s a summary of each company’s valuation.